Could a blood test predict Alzheimer's disease 16 years before symptoms?
February 19, 2019 at 06:04 AM EST
In a 405-person clinical trial, Quanterix's technology was able to detect upticks on a potential biomarker as much as 16 years before the participant began showing symptoms.